found glp 1 reviews GLP-1 receptor agonists were originally developed to treat people with type 2 diabetes. More recently, GLP-1 drugs have been trialled in people with obesity. Three Cochrane have that three drugs ( Systematic review and meta-analysis found

The fact that these substances have been nominated and are being reviewed does not mean they will be added to the 503A Bulks List

Potassium Other symptoms of hypokalemia to look out for include: Constipation Fatigue Muscle weakness Paralysis Nausea Diarrhea Abdominal cramping Weak or irregular pulse Muscle weakness Numbness People with kidney problems, heart problems, diabetes, and those taking certain medications (like drugs to lower blood pressure) are at increased risk for this health issue

This helps limit side effects, but it may also mean progress feels slower or inconsistent for a while

The mentioned potential benefits hold true in general for any transdermal delivery system and not GLP- patches specifically, as these still lack real-world evidence

doi:10.1016/j.amjsurg.2005.08.020